International Conference on Personalized Oncology
12 October 2017
I.M.Sechenov First Moscow State Medical University, Moscow


Personalized Oncology:
Through the View of Idea, Practice, Health and Translational Pipelines
Moscow October 12, 2017


10.00-10.15 OPENING



Sergey Suchkov
Personalized Medicine (PM) through the View of Modern Philosophy to suit Healthcare Model and Translational Armamentarium to secure the latter: from The Past through the Future
Center for Personalized Medicine, I.M.Sechenov First Moscow State Medical University (Sechenov University) and Dept for Translational Medicine, Moscow Engineering Physical Institute (MEPhI), Russia; EPMA, Brussels, EU; PMC & ACS, Washington, DC, USA; ISPM, Tokyo, Japan



John Mendelsohn
Precision Cancer Medicine: Achievements and Prospects
Institute of Personalized Cancer Therapy & Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, USA


Fundamentals of Personalized and Precision Medicine


Roger Kamm
Microfluidic technologies for drug screening, point-of-care assays, and disease models: Applications to cancer
Mechanobiology & Microfluidics Laboratory and NSF Science and Technology Center on Emergent Behaviors of Integrated Cellular Systems, MIT, Cambridge, MA, USA



David Smith
Whole genome sequencing strategies for the treatment of patients with oropharyngeal squamous cell carci-noma
Department of Laboratory Medicine and Pathology and Chairman, Technology Assessment Group, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA



Evgenyi Nikolaev
Proteomics as applicable to Oncology
Skolkovo Institute of Science and Technology, Moscow region, Moscow Institute of Physics and Technology, Dolgoprudnyj, Moscow region, Institute for Energy Problems of Chemical Physics Russian Academy of Sciences, Moscow



Carlos Malpica
Precision Metabolomics applied to Personalized Oncology
European Director, Metabolon Inc., Madrid, Spain



Nikolai Bovin
Personalized oncology through the View of The Diagnostic and Therapeutic Resources of the Newest Generation
Division for Chemical Biology of Glycans and Lipids, Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia, and CSO, KODE Biotech, Auckland, New Zealand



Shawn Murphy
Integrating Genomic and Clinical Data for Precision Medicine
Harvard Medical School, Research Information Systems and Computing, Partners HealthCare and Massachusetts General Hospital, Boston, MA, USA


Modern Clinical Models in Personalized Oncology


Marina Sekacheva
Personalized Treatment to target colorectal cancer 2.0: from RAS through Multitargeting
Center for Personalized Oncology, I.M.Sechenov First Moscow State Medical University, Moscow, Russia



Vladimir Lazar
Development and validation of a new technology and biomarker strategy to predict the efficacy of combinations of targeted cancer therapies: The Model of Lung Cancer
WIN Consortium, Paris, France



Evgeniya Kogan and Sofia Demura
Pathomorphology and Its Armamentarium as applicable to Personalized Oncology: Diagnostic, Predictive and Prognostic Protocols to Monitor Lung Cancer Development
I.M.Sechenov First Moscow State Medical University and Aston Group, Moscow,Russia



Chui Woo Kim
Smart Cancer Screening: A Tool for Personalized Medicine
Bioinfra and Professor, Seoul National University (SNU) and SNU College of Medicine Research Center, Seoul, South Korea



Hans Lentzen
From an Attractive Academic Idea and Promising Pharma Model through a step of Basic Research and Translational Bridging to suit Precision medicine – an example for Interdisciplinary Cooperation in Personalized Oncology
MELEMA Pharma GmbH, Hamburg-Cologne, Germany